Exact Mass: 505.1364
Exact Mass Matches: 505.1364
Found 123 metabolites which its exact mass value is equals to given mass value 505.1364
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyanidin 3-O-(6'-malonyl-arabinoside)
Cyanidin 3-O-(6-malonyl-arabinoside) is a polyphenol compound found in foods of plant origin (PMID: 20428313)
N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-amine
N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide
Peonidin 3-(6'-acetyl-galactoside)
Peonidin 3-(6-acetyl-galactoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-(6-acetyl-galactoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-acetyl-galactoside) can be found in highbush blueberry and lowbush blueberry, which makes peonidin 3-(6-acetyl-galactoside) a potential biomarker for the consumption of these food products.
Peonidin 3-(6'-acetyl-glucoside)
Peonidin 3-(6-acetyl-glucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Peonidin 3-(6-acetyl-glucoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Peonidin 3-(6-acetyl-glucoside) can be found in common grape, grape wine, highbush blueberry, and lowbush blueberry, which makes peonidin 3-(6-acetyl-glucoside) a potential biomarker for the consumption of these food products.
Peonidin 3-(6-acetylglucoside)
beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-tyrosyl]glucopyranoside
Glu Asp Gln Asp
2-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]acetic acid
Ala Asp Asp Trp
Ala Asp Trp Asp
Ala Trp Asp Asp
Asp Ala Asp Trp
Asp Ala Trp Asp
Asp Asp Ala Trp
Asp Asp Glu Gln
Asp Asp Gln Glu
Asp Asp Trp Ala
Asp Glu Asp Gln
Asp Glu Glu Asn
Asp Glu Gly Trp
Asp Glu Asn Glu
Asp Glu Gln Asp
Asp Glu Trp Gly
Asp Gly Glu Trp
Asp Gly Trp Glu
Asp Asn Glu Glu
Asp Gln Asp Glu
Asp Gln Glu Asp
Asp Trp Ala Asp
Asp Trp Asp Ala
Asp Trp Glu Gly
Asp Trp Gly Glu
Glu Asp Asp Gln
Glu Asp Glu Asn
Glu Asp Gly Trp
Glu Asp Asn Glu
Glu Asp Trp Gly
Glu Glu Asp Asn
Glu Glu Asn Asp
Glu Gly Asp Trp
Glu Gly Trp Asp
Glu Asn Asp Glu
Glu Asn Glu Asp
Glu Gln Asp Asp
Glu Trp Asp Gly
Glu Trp Gly Asp
Gly Asp Glu Trp
Gly Asp Trp Glu
Gly Glu Asp Trp
Gly Glu Trp Asp
Gly Trp Asp Glu
Gly Trp Glu Asp
Asn Asp Glu Glu
Asn Glu Asp Glu
Asn Glu Glu Asp
Gln Asp Asp Glu
Gln Asp Glu Asp
Gln Glu Asp Asp
Trp Ala Asp Asp
Trp Asp Ala Asp
Trp Asp Asp Ala
Trp Asp Glu Gly
Trp Asp Gly Glu
Trp Glu Asp Gly
Trp Glu Gly Asp
Trp Gly Asp Glu
Trp Gly Glu Asp
4-[[5-(acetylamino)-1-methyl-1H-indol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]-Benzamide
Cyanidin 3-O-(6-malonyl-arabinoside)
2,2-[[3-acetamido-4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]diethyl diacetate
4-Methoxyphenyl 3-O-Benzyl-2-deoxy-2-phthalimido-beta-D-glucopyranoside
9H-Carbazole, 9-[1,1-biphenyl]-4-yl-3-(4-chlorophenyl)-6-phenyl-
(S)-2-[[3,5-Bis(trifluoromethyl)phenyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide
Dasatinib hydrate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
4-Methylumbelliferyl2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside
Omipalisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3]. Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3].
4-Methylumbelliferyl 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-Galactopyranoside
peonidin 3-O-(6-O-acetyl-beta-D-glucoside)
An anthocyanin cation that is peonidin substituted at position 3 by a 6-O-acetyl-beta-D-glucosyl residue.
N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide
5-chloro-2-propyl-3-[4-[4-[2-(2H-tetrazol-5-ylmethyl)phenyl]phenyl]phenyl]imidazo[4,5-b]pyridine
2,4-difluoro-N-[2-methoxy-4-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide
2-[[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
2-[[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
2-[(4-chlorophenyl)sulfonylamino]-N-[2-(4-morpholinyl)-2-thiophen-2-ylethyl]benzamide
4-[(5-acetamido-1-methylindol-3-yl)methyl]-3-methoxy-N-(2-methylphenyl)sulonylbenzamide
[(1S)-2-[(2,5-difluorophenyl)methyl]-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[(1R)-2-[(2,5-difluorophenyl)methyl]-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
2-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]acetic acid
SRT 1720 (monohydrochloride)
SRT 1720 monohydrochloride is a selective and orally active activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3[1].